Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Feb;74(1):59-62.
doi: 10.1136/sti.74.1.59.

Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro

Affiliations

Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro

M Tanaka et al. Sex Transm Infect. 1998 Feb.

Abstract

Background and objectives: Gonococcal fluoroquinolone resistance is now a significant problem in Japan. We generated gonococcal mutants resistant to norfloxacin in vitro from norfloxacin sensitive isolates and analysed the contribution of three known mechanisms of quinolone resistance in Neisseria gonorrhoeae.

Materials and methods: Three clinical isolates of N gonorrhoeae susceptible to norfloxacin were exposed to increasing concentrations of norfloxacin. To identify mutations in the gyrA and parC genes of the gonococcal mutants, the quinolone resistance determining regions of the gyrA and parC genes were polymerase chain reaction (PCR) amplified and the PCR products were directly sequenced. Norfloxacin accumulation in the gonococcal cells was also measured.

Results: The MICs of norfloxacin for three variants containing a single GyrA mutation were 16-fold higher than that for their parent isolates. A variant showing reduced norfloxacin accumulation in the cells, without mutations in the GyrA or ParC proteins, was also less sensitive to norfloxacin, with a 16-fold increase in the MIC, compared with the parent strain. The MIC of norfloxacin for a variant which contained a single GyrA mutation with reduced norfloxacin accumulation in the cells was 128-fold higher than for the parent strain. A variant containing mutations in both GyrA and ParC proteins with reduced accumulation of norfloxacin in the cells showed a 256-fold increase in the norfloxacin MIC compared with the parent strain. There was no variant containing a ParC mutation without the simultaneous presence of a GyrA mutation.

Conclusions: The results from this study suggest that not only a mutation in the gyrA gene but also reduced drug accumulation in cells contributes to the development of fluoroquinolone a mutation in the gyrA gene contributes to a high level of fluoroquinolone resistance in gonococci with decreases in accumulation in cells having an additional but lesser effect.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Antimicrob Agents Chemother. 1992 May;36(5):1151-4 - PubMed
    1. Antimicrob Agents Chemother. 1992 Feb;36(2):277-82 - PubMed
    1. Antimicrob Agents Chemother. 1993 May;37(5):1086-94 - PubMed
    1. Genitourin Med. 1993 Jun;69(3):196-200 - PubMed
    1. Genitourin Med. 1994 Apr;70(2):90-3 - PubMed